Vaccine protects mice from 1918 flu virus

Oct 17, 2006

U.S. medical researchers say they've developed a vaccine that protects mice against the killer 1918 influenza virus.

The National Institutes of Health scientists say they also have created a technique for identifying antibodies that neutralize that deadly virus, a tool that could help contain future pandemic flu strains.

The findings are important to understanding and preventing the recurrence of the H1N1 influenza virus that caused the 1918 pandemic, and for protecting against virulent flu strains in the future, including the H5N1 avian flu virus.

"Understanding why this influenza virus was so deadly is an extremely important question," said NIAID Director Dr. Anthony Fauci "By building upon earlier research where scientists successfully reconstructed the 1918 pandemic flu strain, Dr. Nabel and his colleagues have demonstrated that this virus is vulnerable to intervention.

The 1918-1919 influenza pandemic was the most deadly flu outbreak in modern history, killing 50 million or more people worldwide.

The study -- led by Dr. Gary Nabel, director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases -- appears online in the Proceedings of the National Academy of Sciences.

Copyright 2006 by United Press International

Explore further: Flu vaccine may hold key to preventing heart disease

add to favorites email to friend print save as pdf

Related Stories

Google profit dips to $2.8 bn

4 hours ago

Google said Thursday its profit in the past quarter dipped slightly from a year earlier, even as revenues for the technology giant showed a sharp increase.

Shrinking resource margins in Sahel region of Africa

5 hours ago

The need for food, animal feed and fuel in the Sahel belt is growing year on year, but supply is not increasing at the same rate. New figures from 22 countries indicate falling availability of resources per ...

Recommended for you

Supercomputers link proteins to drug side effects

Oct 20, 2014

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

Oct 20, 2014

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments : 0